PAVmed (PAVM) Cash & Current Investments (2015 - 2026)

PAVmed has reported Cash & Current Investments for 12 years, with the latest figure at $3.8 million in Q2 2026.

• On a quarterly basis, Cash & Current Investments fell 89.57% year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $3.8 million, a 89.57% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, up 3.64% from the prior year.
• Cash & Current Investments was $3.8 million for Q2 2026 at PAVmed, up from $1.5 million in the prior quarter.
• The five-year high for Cash & Current Investments was $65.2 million in Q2 2022, with the low at $1.5 million in Q4 2024.
• Average Cash & Current Investments over 5 years is $32.3 million, with a median of $31.9 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments tumbled 92.44% in 2024, then soared 83.82% in 2025.
• Over 5 years, Cash & Current Investments stood at $39.7 million in 2022, then slumped by 50.59% to $19.6 million in 2023, then sank by 92.44% to $1.5 million in 2024, then climbed by 3.64% to $1.5 million in 2025, then soared by 146.03% to $3.8 million in 2026.
• The last three Cash & Current Investments figures came in at $3.8 million (Q2 2026), $1.5 million (Q4 2025), and $31.9 million (Q3 2025), per Business Quant data.